ARCHIVES

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

Organ Systems Support Contract To Cost More than OSCC Grant

September 30, 1988

Bypass Budget Is Realistic, Defensible Plan, Broder Says

September 27, 1991

National Standards For Science Education Issued By Committee Led By NCI Director

December 15, 1995

European Compound enhances IL-2 In BRMP Mouse Study; BRMP Mouse Study; Rosemberg Describes System Improvements, Updates Results

June 5, 1987

Senate Subcommittee Oks $850Million for Cancer; NCI Reveals How It Would Spend Fiscal 1978 Funds

June 18, 1976

ACS: Decline in Death Rates Saved Over 1.3 Million Lives

January 10, 2014